Rehabilitation in Patients With Pulmonary Fibrosis
Assessment of Improvement in Functional Status of Patients With Pulmonary Fibrosis After Exercise Rehabilitation Program
1 other identifier
observational
60
0 countries
N/A
Brief Summary
This study aims to explore the effects of exercise rehabilitation on the functional status of patients with pulmonary fibrosis, assessing both physical and psychological dimensions of health. By identifying significant improvements, we can contribute to the development of comprehensive rehabilitation strategies that enhance patient outcomes and foster a better quality of life for those affected by this challenging condition
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2025
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 5, 2024
CompletedFirst Posted
Study publicly available on registry
November 6, 2024
CompletedStudy Start
First participant enrolled
January 20, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 20, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 20, 2025
CompletedNovember 6, 2024
October 1, 2024
5 months
November 5, 2024
November 5, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
**Asses Health-Related Quality of Life:**
Assessed through validated questionnaires such as the St. George's Respiratory Questionnaire (SGRQ)
Baseline
Eligibility Criteria
\*\*Demographic Data Collection:\*\* * Age, sex, duration of pulmonary fibrosis, and medical history. 2\. \*\*Pulmonary Function Testing:\*\* * Spirometry will be conducted to assess Forced Vital Capacity (FVC) and Forced Expiratory Volume in one second (FEV1). 3\. \*\*Functional Capacity Assessment:\*\* * The Six-Minute Walk Test (6MWT) will be performed to evaluate baseline exercise tolerance. 4\. \*\*Quality of Life Evaluation:\*\* * Health-related quality of life will be assessed using the St. George's Respiratory Questionnaire (SGRQ) or Chronic Respiratory Disease Questionnaire (CRQ). 5\. \*\*Dyspnea Assessment:\*\* * Dyspnea levels will be measured using the Modified Medical Research Council (mMRC) dyspnea scale. * Exercise Rehabilitation Program Participants will engage in a structured 8-week exercise rehabilitation program, which includes: * \*\*Supervised Exercise Sessions:\*\* * Participants will attend twice-weekly sessions led by trained physiotherapists, focusing on aerobic
You may qualify if:
- \. \*\*Diagnosis of Pulmonary Fibrosis:\*\*
- Patients must have a confirmed diagnosis of pulmonary fibrosis, as determined by clinical evaluation and imaging studies (e.g., high-resolution computed tomography).
- \. \*\*Age Range:\*\*
- Participants should be adults aged 18 years and older to capture the adult population affected by the disease.
- \. \*\*Stable Clinical Condition:\*\*
- Patients must be in a stable clinical condition, defined as no exacerbations or significant changes in treatment for at least four weeks prior to enrollmen
You may not qualify if:
- \. \*\*Other Significant Lung Diseases:\*\*
- Patients with concurrent respiratory conditions (e.g., chronic obstructive pulmonary disease, asthma, or lung cancer) that could confound the results.
- \. \*\*Acute Exacerbations:\*\*
- Individuals experiencing an acute exacerbation of pulmonary fibrosis or any significant respiratory illness within four weeks prior to enrollment.
- \. \*\*Severe Comorbidities:\*\*
- Patients with severe cardiovascular disease, uncontrolled hypertension, major neurological disorders, or musculoskeletal problems that would impede participation in exercise.
- \. \*\*Cognitive Impairment:\*\*
- Individuals with cognitive impairments that prevent them from understanding the study procedures or following the rehabilitation program.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (1)
Troosters T, Janssens W, Demeyer H, Rabinovich RA. Pulmonary rehabilitation and physical interventions. Eur Respir Rev. 2023 Jun 7;32(168):220222. doi: 10.1183/16000617.0222-2022. Print 2023 Jun 30.
PMID: 37286219RESULT
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Doctor
Study Record Dates
First Submitted
November 5, 2024
First Posted
November 6, 2024
Study Start
January 20, 2025
Primary Completion
June 20, 2025
Study Completion
August 20, 2025
Last Updated
November 6, 2024
Record last verified: 2024-10
Data Sharing
- IPD Sharing
- Will not share